Michelle

Sabo

MD

PhD

related links

Bio

Dr. Sabo's research is focused on better characterizing immunologic function in the female reproductive tract.  Specifically, she is working to define how differences in vaginal microbiota influence inflammatory changes in the cervix and contribute to adverse reproductive health outcomes. 

Dr. Sabo has been awarded an NIH K23 Career Development grant to study how sub-optimal microbiota alter cervical dendritic cell number and function, for which sample analysis is currently underway.  Additionally, Dr. Sabo is the recipient of a CFAR New Investigator Award to evaluate differences in cervical immune cell types using RNA sequencing in women with and without bacterial vaginosis. 

Clinically, Dr. Sabo has an academic interest in infections resulting from congenital (primary) immune deficiencies, and founded a clinic to care for adult patients proven or potential immune dysfunction. 

research interests

• Characterizing immune cell types and cell signaling in the cervico-vaginal tract
• Evaluating how changes in vaginal microbiota alter cervical inflammation
• Understanding the role of vaginal microbiota in HIV acquisition risk

Clinical Interests

• HIV 
• General Infectious Diseases
• General Internal Medicine
• Infectious Diseases in Immune-compromising conditions

education & training

MS, Duquesne University, Pittsburgh PA (2005)

MD/PhD, Washington University in St. Louis School of Medicine, St. Louis MO (2013)

Intern, Department of Medicine, University of Washington, Seattle WA (2013-2014)

Resident, Department of Medicine, University of Washington, Seattle WA (2014-2016)

Fellow, Division of Allergy & Infectious Diseases, University of Washington, Seattle,WA (2016-2019)

honors

Alpha Omega Alpha Medical Honor Society, Washington University in Saint Louis, 2013

Infectious Disease Society of Obstetrics and Gynecology Trainee Travel Scholar, 2017

CROI Young Investigator Award, 2019

publications